CLINICAL ROLE -
July 23rd 2025
June 18th 2025
Lenacapavir becomes the first and only twice-yearly option for HIV prevention.
March 20th 2025
As HIV treatment and prevention evolve, the use of long-acting injectables and their role in combating the HIV epidemic grows.
March 17th 2025
Data from conference abstracts and presentations indicate that both preexposure prophylaxis methods continue to demonstrate efficacy.
January 9th 2025
Pharmacists' accessibility and expertise in medication management make them ideal health care providers to discuss prevention strategies, medication adherence, and potential adverse effects.
How Can Pharmacists Best Support Patients With HIV?
Patients with HIV can now expect to live into old age, and therefore need links to the community health network.
Read More
Opioid Agonist Therapy Most Cost-Effective in HIV Prevention
Scientists project combining prevention programs could avert up to 40,000 HIV infections over 20 years among injection drug users.
Brain Connectivity Inhibited in HIV-Positive Youth
HIV infection may affect cognition in young patients.
Antiretroviral Treatment Postpartum Improves Health in HIV-Positive Mothers
Continuing ART post-delivery shows benefits in women with early stage HIV,
Growing Old With HIV: Polypharmacy Carries Additional Risks
Patients with HIV have nearly twice the risk of ischemic heart disease, heart failure, and myocardial infection.
Polypharmacy Risks in Older Patients With HIV
As patients with HIV age, they develop chronic conditions associated with older age and take more medication.
Aging With HIV Carries New Set of Problems
HIV has become a chronic disease that requires a different strategy with aging patients.
Implications of HIV as a Long-Term Chronic Disease
Data discusses the unique issues senior patients with HIV face.
What Influences COPD Risk in HIV-Positive Patients?
The risk of comorbid chronic obstructive pulmonary disorder in patients infected with HIV may be underestimated.
Could A Newly Identified HIV Reservoir Be the Key to an HIV Cure?
Study provides first direct evidence of HIV persistence in tissue macrophages in vivo, which could lead to a cure for HIV.
Newer Cholesterol Drug Outperforms Pravastatin in HIV Patients
Pitavastatin reduced LDL cholesterol with little impact on HIV-1 RNA and CD4 cell counts.
New Cholesterol Drug Shows Superiority to Pravastatin in HIV Patients
Pitavastatin lowered LDL cholesterol levels in patients with HIV and dyslipidemia.
Counseling on Supplement Use in Patients with HIV
Nearly 70% of patients with HIV take dietary supplements with their antiretroviral therapy.
Global Effort Needed to Cure HIV
The dream of an HIV cure will only be realized if all 35 million people who are living with the virus adhere to treatment.
Criminalized Same-Sex Behavior May Influence HIV Testing Rates
Countries where high risk populations face punitive laws do not have access to critical HIV prevention services.
Cytomegalovirus Presents Problem for HIV Patients Treated with ART
Cytomegalovirus disease coinfection without symptoms is common in people with HIV.
Nanotechnology Significantly Reduces HIV Drug Dosage
Chronic oral dosing of HIV treatments can have significant complications caused by high pill burden.
Study Shows Promise Improving HIV Diagnoses and Treatment Uptake
Research seeks to improve the impact of household-based HIV testing and the link to care by community HIV care providers.
VA Mail-Order System for HIV Care Shows Positive Trend
Researchers from the VA system examined how mail-order delivery of drugs affects their patients with HIV.
Treating HIV and Tuberculosis Co-infection
Clinicians should screen all newly diagnosed HIV patients for tuberculosis.
How HIV Can Infect Macrophages
Even macrophages aren’t safe from HIV.
Experimental HIV Drug May Prevent New Infections
Biologic HIV drug may reduce new infections among high risk populations.
Investigational Biologic May Treat, Prevent HIV
A broadly neutralizing antibody was observed to reduce HIV viral load and prevent transmission.
Nine-Step System Proposed to Evaluate HIV Preventative Care
New system could improve the implementation of pre-exposure prophylaxis-based care for HIV prevention.
Overcoming Barriers in the Use of HIV PrEP
Although PrEP is highly effective, few appropriate patients with HIV currently use it.
Men May Engage in Riskier Sex in the Era of HIV Treatment as Prevention
Statistics show condomless sex is on the rise among men who have sex with men.
The Risk of COPD in Patients With HIV
Comorbid chronic obstructive pulmonary disorder may be underestimated in patients with HIV.
Declining Hepatitis C Drug Costs Highlights Specialty Pharmacy Week in Review
Top articles of the week on Specialty Pharmacy Times.
Rates of Hepatitis C Coinfection in Patients With HIV
For patients with HIV, liver disease is a major cause of morbidity and mortality.
Social Media Helps Track HIV Transmission Rates
Social media can identify behavioral trends and attitudes relevant to the risk of infection with HIV.
